Fortress Biotech
FBIO
51 hedge funds and large institutions have $18.1M invested in Fortress Biotech in 2016 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 19 increasing their positions, 11 reducing their positions, and 3 closing their positions.
5,480% more call options, than puts
Call options by funds: $279K | Put options by funds: $5K
73% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 11
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
1% more capital inflows, than outflows
Capital inflows: $2.06M | Capital outflows: $2.05M
0% more funds holding
Funds holding: 51 → 51 (0)
0.91% less ownership
Funds ownership: 14.62% → 13.71% (-0.91%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$765K |
| 2 |
BlackRock Fund Advisors
San Francisco,
California
|
+$404K |
| 3 |
Morgan Stanley
New York
|
+$229K |
| 4 |
BlackRock Institutional Trust
San Francisco,
California
|
+$122K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$108K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Elliott Management
New York
|
-$1.42M |
| 2 |
Avoro Capital Advisors
New York
|
-$389K |
| 3 |
Goldman Sachs
New York
|
-$64K |
| 4 |
Bank of New York Mellon
New York
|
-$56.4K |
| 5 |
HighPoint Advisor Group
Downers Grove,
Illinois
|
-$35K |
FBIO Hedge Fund Activity: Q4 2016 in Review
51 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech (FBIO) for Q4 2016, worth a combined $18.1M — down 15% from $21.2M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new FBIO positions and 3 closed out — a net gain of 1 holder — while 19 added to existing stakes and 11 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $765K. The largest seller was Elliott Management, exiting entirely with an estimated $1.42M sold.
- 51 institutional investors held Fortress Biotech (FBIO) as of Q4 2016, unchanged from Q3 2016.
- Funds reported $18.1M of Fortress Biotech stock for Q4 2016, down 15% quarter-over-quarter.
- 4 funds opened new Fortress Biotech positions in Q4 2016 and 3 closed out, a net change of +1 holder.
- The largest Fortress Biotech buyer in Q4 2016 was Millennium Management, an estimated $765K added.
- The largest Fortress Biotech seller in Q4 2016 was Elliott Management, an estimated $1.42M sold.
Based on aggregated 13F filings for Q4 2016.